Detalhe da pesquisa
1.
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer.
Prostate
; 84(1): 100-110, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37796107
2.
Evaluation of initial prostate cancer biopsies utilizing 3D open-top light-sheet microscopy for detection of early disease.
Prostate
; 83(11): 1121-1124, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165548
3.
Clinical, pathologic, and molecular features of amphicrine prostate cancer.
Prostate
; 83(7): 641-648, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779357
4.
Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.
J Urol
; 209(2): 354-363, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621991
5.
Mismatch repair deficiency and clinical implications in prostate cancer.
Prostate
; 82 Suppl 1: S37-S44, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358351
6.
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations.
Prostate
; 81(16): 1382-1389, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516663
7.
Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high-risk localized prostate cancer.
Prostate
; 81(7): 418-426, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33755225
8.
Clinical determinants for successful circulating tumor DNA analysis in prostate cancer.
Prostate
; 79(7): 701-708, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865311
9.
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.
Lancet Oncol
; 19(1): 76-86, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248236
10.
11.
Prognostic and therapeutic implications of DNA repair gene mutations in advanced prostate cancer.
Clin Adv Hematol Oncol
; 15(10): 785-795, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29040258
12.
Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study.
Prostate
; 76(13): 1218-26, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27338150
13.
A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling.
Prostate
; 76(14): 1303-11, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27324988
14.
Immunotherapy for prostate cancer: recent developments and future challenges.
Cancer Metastasis Rev
; 33(2-3): 641-55, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24477411
15.
Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer.
Prostate
; 75(15): 1814-20, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26306637
16.
Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone.
Prostate
; 74(13): 1278-85, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25053178
17.
Clinical activity of enzalutamide in Docetaxel-naïve and Docetaxel-pretreated patients with metastatic castration-resistant prostate cancer.
Prostate
; 74(15): 1560-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25176007
18.
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177Lu-PSMA-617: A Retrospective Multicenter Cohort Study.
JCO Precis Oncol
; 8: e2300634, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662984
19.
A Signal-finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1.
Clin Cancer Res
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512117
20.
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration.
Prostate Cancer Prostatic Dis
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383885